WHO comments on United States’ announcement of intent to withdraw

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-17T08:21:32.243Z • Permanent link

Regrettable news has been announced by the World Health Organization (WHO) that the United States of America intends to withdraw from the organization, effective immediately. This decision comes after months of escalating tensions between the U.S. government and the WHO, which has been at the forefront of global efforts to combat the COVID-19 pandemic. Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, expressed his disappointment and concern over the decision in a statement, highlighting the critical role the organization plays in ensuring global health security.

The U.S. withdrawal is a significant development in the ongoing debate over the WHO's governance structure and funding. The WHO has been under pressure from some member states, including the U.S., to reform its leadership and address concerns over its perceived bias towards certain countries. The U.S. government has been a major contributor to the WHO's budget, with the country providing over $400 million annually since 2016. However, the Trump administration's criticism of the WHO's handling of the pandemic has led to increased tensions between the two nations.

The decision to withdraw from the WHO has sent shockwaves through the global health community, with many countries expressing concerns over the potential consequences for global health security. The WHO's leadership has vowed to continue its critical work, despite the loss of a major contributor. The organization's ability to respond to global health crises will be significantly impacted, and the move may embolden other countries to re-evaluate their relationships with the WHO.

The withdrawal of the United States from the World Health Organization has significant implications for global health security and the pharmaceutical industry. Companies such as Pfizer and Moderna, which have played a critical role in the development and distribution of COVID-19 vaccines, will be directly impacted by the decision. The WHO's expertise and resources will also be lost, potentially slowing the development of new treatments and therapies for future pandemics.

The move has also raised concerns over the future of the WHO's pandemic preparedness and response efforts. The organization's ability to respond quickly and effectively to emerging health crises will be compromised, potentially putting lives at risk. The WHO's leadership has vowed to continue its critical work, but the loss of U.S. funding and expertise will be significant. The pharmaceutical industry will also be impacted, as the WHO's expertise and resources are lost, potentially slowing the development of new treatments and therapies for future pandemics.

The U.S. withdrawal from the World Health Organization is part of a broader pattern of tensions between the U.S. government and international institutions. The Trump administration's criticism of the WHO and other international organizations has been a hallmark of its foreign policy, with the U.S. government expressing concerns over the perceived bias and lack of transparency within these organizations. However, this move is also part of a larger debate over the future of global governance and the role of international institutions in addressing global challenges.